What Celer Biotecnologia does

Celer Biotecnologia S.A. is a Brazilian biotechnology company founded in 2001 and headquartered in Belo Horizonte, Minas Gerais, specializing in Point-of-Care Testing (POCT) diagnostic equipment for human and veterinary health applications. The company develops and manufactures diagnostic platforms including the Finecare immunofluorescence line for cardiac, inflammatory, infectious disease, and hormone markers; the LOC-200 dry biochemistry analyzer; coagulation analyzers; blood gas analyzers; and hematology analyzers. Celer also expanded into molecular biology diagnostics (2020) and secured ANVISA authorization for COVID-19 self-tests distributed via e-commerce (2022).

The company's business model centers on direct B2B sales to clinical laboratories, hospitals, and veterinary practices, supplemented by a regional reseller network (notably Biomega operating across six Brazilian states) and distribution partnerships with international diagnostic firms including BIOSYNEX (France) and Wondfo Biotech (China). Celer also operates consumer-direct channels through online autotest sales. The company maintains regulatory certifications including AFE ANVISA (2009) and CBPF (2012) and holds multiple product registrations with the Brazilian health authority.

With 11-50 employees and a CNPJ registration (04.846.613/0001-03), Celer has built a 25+ year operational track record. Historical capital sources include FAPEMIG/CNPq/FINEP grants (2006), Fundo CRIATEC investment, and a 2008 funding round of approximately $857,480 from Inseed Investimentos and KPTL. The company was recognized as a Brazilian market leader in POCT cardiac, inflammatory, and hemostasis markers at CBDL 2024.

Name

Celer Biotecnologia

Legal name

Celer Biotecnologia S.A.

Website

https://celer.ind.br

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

Celer Biotecnologia is a Belo Horizonte-based Brazilian biotech company founded in 2001 that develops and manufactures Point-of-Care Testing (POCT) diagnostic equipment, including immunofluorescence (Finecare), biochemistry, coagulation, and molecular biology analyzers, serving clinical laboratories, hospitals, and veterinary practices across Brazil.

Ownership category

akta.pro rank

Product category

Clinical Diagnostic Equipment (POCT)

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH)

akta.pro secondary industries

Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Reference Laboratory Testing (Clinical Pathology & Chemistry) (HLAMADAA)

Keywords

• Point of care diagnostics
• Clinical diagnostic equipment
• Veterinary diagnostics
• Immunofluorescence analyzers
• Rapid diagnostic tests

Headquarters

HQ city

Belo Horizonte

HQ country

Brazil

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Diagnostic Equipment Sales: Sale of diagnostic instruments including Finecare systems, hematology analyzers, dry biochemistry analyzers, coagulation analyzers, and blood gas equipment to healthcare facilities.
2. Diagnostic Test Kits and Reagents: Consumable test cassettes, reagent discs, and test kits for various biomarkers including cardiac markers, inflammatory markers, hormones, and infectious disease tests.
3. COVID-19 Rapid Tests: Rapid antigen and antibody tests for COVID-19 including autotest products for consumer use.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Celer Biotecnologia develops, manufactures, and distributes Point of Care Testing (POCT) diagnostic instruments and rapid test kits for both human and veterinary clinical diagnostics. The portfolio includes immunofluorescence analyzers (Finecare III, PLUS, SE, FX1, and Finecare Veterinário), dry biochemistry analyzers (LOC-200, CelerCare), blood gas analyzers (UCare 6000), coagulation analyzers, and a 4-part hematology analyzer, along with associated consumable reagent kits and rapid antigen/PCR tests for cardiac, inflammatory, infectious disease, thyroid, fertility, and coagulation biomarkers. The company also distributes BIOSYNEX rapid tests (HIV, celiac, women's health) and offers a small consumer-facing line of self-tests.

Product overview

Celer Biotecnologia is a Brazilian biotechnology company specializing in clinical and veterinary diagnostic solutions. The company offers an integrated portfolio of Point of Care Testing (POCT) equipment and rapid tests across multiple technology platforms including immunofluorescence (Finecare line: SE, PLUS, III, FX1, and Veterinário), dry biochemistry (LOC-200, CelerCare), blood gas analysis (UCare 6000, Analisador de Gases Sanguíneos), coagulation analysis (human and veterinary analyzers), and hematology (Celer Vet hematology analyzer). The product ecosystem includes comprehensive test panels for cardiac markers (Troponin I, BNP, NT-proBNP, D-Dimer, CK-MB, H-FABP), inflammatory markers (CRP, PCT, IL-6), thyroid hormones (TSH, fT3, fT4), infectious diseases (Dengue, COVID-19, HPV, HIV, Chlamydia), coagulation factors, and metabolic parameters. The company also distributes BIOSYNEX products including celiac disease self-tests and women's health diagnostics. Equipment features Wi-Fi and Bluetooth connectivity with LIS interface capability for laboratory integration.

Differentiator

Problem solved

Functional benefit

Brands

• Finecare: Point of Care Testing (POCT) equipment line for immunofluorescence detection and quantification of analytes in blood samples
• Celer Covid-19

Products and services

• Finecare III (FIA Meter III Plus) Point-of-care fluorescence immunodetection system for quantitative detection of various analytes in blood, with internal carousel allowing 20 simultaneous tests, 10-inch color LCD touchscreen, and ANVISA registration 80537410046. Used by hospitals, laboratories, and clinics for cardiac, inflammatory, infectious disease, thyroid, fertility, and metabolic testing.
• Finecare Plus Portable point-of-care multiparametric immunoassay system by fluorescence for detection and quantification of analytes in blood, with lightweight compact design supporting standard and rapid test modes. ANVISA registration 80537410040.
• Finecare SE Portable multiparametric immunoassay system by fluorescence featuring battery, Wi-Fi, and Bluetooth connectivity, with standard test mode and rapid test mode plus included quality control cassette. ANVISA registration 80537410089.
• Finecare FX1 Portable immunodetection equipment by fluorescence for point-of-care testing, part of the Finecare line distributed by Celer Biotecnologia in Brazil.
• LOC-200 Dry Biochemistry Analyzer Compact spectrophotometric dry biochemistry analyzer delivering results in 8-12 minutes using only 90-120 µL of blood, with integrated centrifuge, QR code reader, intelligent quality control, LIS interface, and Wi-Fi connectivity. ANVISA registration 80537410154.
• CelerCare Dry Biochemistry Analyzer Dry biochemistry analyzer positioned for veterinary and human emergency / patient-monitoring use, providing precise and rapid results in biochemistry, blood gas, and electrolyte segments.
• UCare 6000 Blood Gas Analyzer Blood gas analyzer for evaluation of gas concentrations, pH, ions, and other substances in arterial blood, used for emergency and patient monitoring in human diagnostics.
• Human Blood Gas Analyzer Blood gas analyzer for evaluation of gas concentrations, pH, ions, and other substances in blood in human clinical settings such as emergency rooms and ICUs.
• Human Coagulation Analyzer Portable automated coagulation analyzer (point of care) that calculates five parameters of blood coagulation time (PT, INR, TT, FIB, ACT), with battery, Wi-Fi, and Bluetooth, producing results in approximately 1.5 minutes from a 20 µL sample. ANVISA registration 80537410111.
• Finecare Veterinário (Veterinary POCT Reader) Portable immunofluorescence POCT reader for veterinary analyses, including H-FABP, IL-6, and CRP panels for cardiac, inflammatory, and infectious disease detection in companion and production animals.
• Hematologia Celer Vet (4-Part Veterinary Hematology Analyzer) 4-part hematology analyzer providing rapid and precise analyses for samples from dogs, cats, horses, and cattle, reporting 24 parameters in 36 seconds.
• Veterinary Blood Gas Analyzer Veterinary blood gas analyzer for evaluation of gas concentrations, pH, ions, and other substances in blood, with direct application in emergency procedures for animals.
• Veterinary Coagulation Analyzer Portable automated point-of-care coagulation analyzer for coagulation testing in whole blood treated with sodium citrate, used in veterinary clinics.
• COVID-19 Self-Test Nasal swab rapid antigen self-test for COVID-19 detection with results read in 15 minutes; authorized by ANVISA on 2022-01-28 and sold directly to consumers via the autotestecovid.celer.ind.br storefront and pharmacy channels.
• Dengue NS1 IgG/IgM Rapid Test Rapid immunochromatographic in vitro diagnostic test for qualitative detection and differentiation of dengue NS1 antigen and IgM/IgG antibodies. ANVISA registration 80537410103.
• HPV 16/18 and HPV Genotype PCR Test Real-time PCR test for detection of HPV 16 and 18 plus a genotype test capable of detecting 15 different HPV subtypes; part of the Molecular Biology line launched in 2020.
• Celer Sansure PCR Kit (Chlamydia, Gonorrhea, Ureaplasma) Real-time PCR detection kit for precise diagnosis of Chlamydia trachomatis, Neisseria gonorrhoeae, Ureaplasma urealyticum, and isolated cases, distributed as part of Celer's Molecular Biology portfolio.
• BIOSYNEX Celiac Disease Self-Test Self-test for initial diagnosis of celiac disease with results in up to 10 minutes; easy-to-use home-use format distributed by Celer under the BIOSYNEX partnership.
• BIOSYNEX Distributed Products (Amnioquick, Premaquick, HIV, cryptococcal tests) Portfolio of BIOSYNEX rapid diagnostic tests distributed by Celer in Brazil: Amnioquick and Premaquick (predictive tests for fetal membrane rupture and preterm birth), Exacto HIV rapid screening tests, and cryptococcal infection tests.

Quantifiable outcome

• Results delivered in 3-15 minutes depending on test type
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

Feature5 records

Partnerships

Three partnerships are on record, tiered minor and core.

• UniBH - Agro LabminorStrategic or Co-development Partner · 20 January 2022Partnership with UniBH veterinary medicine laboratory for research development and testing of Celer products by students and faculty. Equipment provided for biochemistry and coagulation research projects.
• BIOSYNEXcoreChannel Partner/ Reseller/ Distributor · 5 November 2021Partnership with French company BIOSYNEX for distribution of rapid diagnostic tests in Brazil. Celer distributes BIOSYNEX products including Amnioquick, Premaquick (women's health), HIV tests, and gluten self-tests. BIOSYNEX chose Celer for their regulatory, commercial, and scientific infrastructure after evaluating over 40 companies.
• Wondfo BiotechcoreTechnology or IntegrationPartnership with Chinese manufacturer Wondfo Biotech for rapid COVID-19 tests and POC equipment. Wondfo is one of four Chinese manufacturers with FDA credibility. Celer imported 1.46 million COVID-19 rapid tests and distributes Wondfo equipment including Finecare systems.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• bioMérieux: French IVD leader with extensive microbiology, immunoassay, and clinical chemistry portfolios sold across Brazilian hospitals. Comparable to Celer in cardiac/inflammatory markers and blood culture workflows, though much larger and broader.
• Siemens Healthineers: Global diagnostics and imaging major with blood gas (RAPIDPoint), immunoassay, and clinical chemistry systems. Overlaps directly with Celer's UCare 6000 blood gas and Finecare panels in hospital tenders.
• Roche Diagnostics: Major global IVD player with cobas POC and cardiac marker offerings (Troponin, NT-proBNP, D-Dimer). Overlaps with Celer's Finecare III cardiac panel and competes for hospital lab budgets in Brazil.
• Abbott Point of Care (i-STAT): Abbott's handheld blood gas/chemistry analyzer and broader POC diagnostics franchise. Directly competes with Celer in blood gas and POCT in Brazilian hospitals, but as part of Abbott's global diagnostics empire.
• HORIBA Medical: Manufacturer of hematology and clinical chemistry analyzers with significant global presence including Latin America. Comparable to Celer's hematology and dry biochemistry lines, particularly in mid-size hospital and lab settings.

Direct peers

• Wondfo Biotech: Chinese manufacturer of the Finecare immunofluorescence POCT platform that Celer distributes in Brazil. Wondfo is Celer's core technology partner and a direct comparable in cardiac/inflammatory POCT assays at the global level.
• BIOSYNEX: French diagnostics company whose rapid tests (Amnioquick, Premaquick, HIV, celiac autotest) Celer distributes in Brazil. Comparable as a focused rapid-diagnostic test portfolio company targeting similar healthcare and consumer end markets.
• Nova Biomedical: US-based manufacturer specializing in blood gas, chemistry, and immunochemistry analyzers including handheld POC systems. Closely comparable to Celer's blood gas and POCT chemistry product family.
• Erba Mannheim: Mid-sized IVD manufacturer offering clinical chemistry, hematology, and POCT analyzers at accessible price points. Closely comparable to Celer as a multi-platform diagnostics equipment vendor targeting emerging and price-sensitive markets.

Emerging players

• Mindray: Chinese IVD and patient-monitoring manufacturer with hematology, chemistry, and POCT products. Comparable as a cost-competitive alternative to multinationals in emerging markets, including Brazil, and overlaps with Celer's hematology and biochemistry analyzers.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UC96gHlpkt1zTwXgCcGP3-cQ
• Facebookfacebook.com/celerbiotecnologia
• LinkedInlinkedin.com/company/celer-biotecnologia-s-a
• Instagraminstagram.com/celerbiotecnologia/?hl=pt-br
• Xx.com/celer_biotec

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Celer Biotecnologia